Print Page     Close Window     

SEC Filings

6-K
AC IMMUNE SA filed this Form 6-K on 03/17/2017
Entire Document
 

 

2.Compensation for Members of Executive Management

 

a.Executive Management Composition

 

The executive management (EM) during 2016 was comprised of:

 

Name Function Appointment
     
Andrea Pfeifer, PhD Chief Executive Officer 2003
George Pavey (1) Chief Financial Officer 2015
Andreas Muhs, PhD Chief Scientific Officer 2005
Jean-Fabien Monin Chief Administrative Officer 2009

 

(1)In a press release dated November 23, 2016 it was announced that the Company had appointed Mr. Joerg Hornstein as Chief Financial Officer to replace Mr. George Pavey, who left the company after the initial public offering. Mr. Hornstein is expected to begin his role as Chief Financial Officer on April 1, 2017. In the meantime, Mr. Monin is acting as our interim principal financial officer.

 

b.Executive Compensation Principles

 

Each member of the EM receives remuneration consisting of a base salary, incentive plan, social benefits and an equity incentive plan as described more fully in the annex to this report.

 

c.2016 Executive Compensation

 

The total compensation of the EM and the highest individual compensation of the members of the Executive Management in 2016 are outlined below:

 

All amounts are in CHF 000’s

 

Name Cash Compensation Other Compensation Pension (employer) Employer's Social Contribution Cash Bonus  Total Stock Options FMV
  2016 2016 2016 2016 2016 2016 2016
Andrea Pfeifer, PhD                             350                            28                     52                         294             305             1,029  
Total Executive Committee Compensation                          1,080                            52                   154                       431             526          2,243                674

 

(1)Stock option value determined based on grant date fair value of stock options using the Black-Scholes model.

 

5


© AC Immune 2015